A detailed history of Hara Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Hara Capital LLC holds 69,954 shares of NVO stock, worth $3.39 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares
69,954
Previous 46,417 50.71%
Holding current value
$3.39 Million
Previous $2.58 Billion 38.19%
% of portfolio
1.98%
Previous 1.52%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

BUY
$45.68 - $59.65 $1.08 Million - $1.4 Million
23,537 Added 50.71%
69,954 $3.56 Billion
Q3 2025

Oct 30, 2025

BUY
$45.38 - $71.7 $2.11 Million - $3.33 Million
46,417 New
46,417 $2.58 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hara Capital LLC Portfolio

Follow Hara Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hara Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hara Capital LLC with notifications on news.